Published in Gene Therapy Weekly, February 27th, 2003
"The HMGB I or HMGB2 expression plasmid, carrying the neo' gene as a selection marker, was introduced into HeLa S3 cells to obtain stably-transfected cells," explained T. Ueda and colleagues, Science University Tokyo, Department of Biological Science and Technology.
"The number of G418-resistant colonies was about 10 times the number of colonies of control cells transfected with plasmids not carrying the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.